No hay productos en el carro de la compra
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Casa > Licensing > BSW202203

Anti-GCC humanized antibody

BLA Filing
  • Project profile
    Project name: Anti-GCC humanized antibody
    Indications: Solid Tumor (Colorectal, gastric and esophageal cancers)
    Research phase: Preclinical
    Cooperation demands: sequence authorization or project transfer
  • Highlights

    1. MoA:

    (1) Guanylate cyclase 2C (GCC) is encoded by GUCY2C gene in human body. The receptor has an extracellular ligand binding domain, a transmembrane region, a region similar to the protein kinase sequence and a c-terminal guanylate cyclase domain. GCC signal pathway can inhibit cell proliferation, protect tight connections between cells, inhibit p53 degradation, promote DNA damage repair, reduce cell cycle progression, and promote oxidative phosphorylation.

    (2) GCC is highly expressed in colorectal cancer, gastric cancer and esophageal cancer, and only in intestinal and colon tissues in normal tissues, but not in other tissues.

    Excellent preclinical results

    2. Excellent preclinical results:

    (1) Compared with Benchmark (PF-07062119), this antibody has better affinity for HEK293T-hGCC cells.

    (2) The binding epitope of the antibody to GCC is different from the natural ligand guanosine protein of GCC.

    (3) The antibody can be rapidly internalized by 293T-hGCC cells.

    (4) GCC-CD3 BsAb can effectively activate Jurkat cells; Activates T-cell-mediated cytotoxic effects.

  • Project Introduction

    1. Asset type: Anti-GCC humanized antibody

    2. Indication: Solid Tumor (Colorectal, gastric and esophageal cancers)

    3. Stage:Preclinical

    4. Cooperation: sequence authorization or project transfer

    5. Research progress:

    (1) Ongoing Preclinical research:
    Anti-GCC humanized antibody has high affinity.
    It is different from the natural GCC ligand binding epitope.
    GCC-CD3 BsAb can activate T cells and T-cell-mediated cytotoxic effects.

Comments (0)

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Correo electrónico
+1 888-377-6111
Lichtstrasse 35,4056 Basel, Switzerland

Dejar un mensaje